Cargando…
Systematic evaluation of cancer‐specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts
BACKGROUND: Genetic risk score (GRS) is an odds ratio (OR)‐weighted and population‐standardized method for measuring cumulative effect of multiple risk‐associated single nucleotide polymorphisms (SNPs). We hypothesize that GRS is a valid tool for risk assessment of most common cancers. METHODS: Util...
Autores principales: | Shi, Zhuqing, Yu, Hongjie, Wu, Yishuo, Lin, Xiaoling, Bao, Quanwa, Jia, Haifei, Perschon, Chelsea, Duggan, David, Helfand, Brian T., Zheng, Siqun L., Xu, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558466/ https://www.ncbi.nlm.nih.gov/pubmed/30968590 http://dx.doi.org/10.1002/cam4.2143 |
Ejemplares similares
-
Improved risk scoring systems for colorectal cancer screening in Shanghai, China
por: Wu, Wei‐Miao, et al.
Publicado: (2022) -
Cancer of unknown primary—Epidemiological trends and relevance of comprehensive genomic profiling
por: Binder, Carmen, et al.
Publicado: (2018) -
Cancer survival disparities by health insurance status
por: Niu, Xiaoling, et al.
Publicado: (2013) -
Evaluation of a prediction model for colorectal cancer: retrospective analysis of 2.5 million patient records
por: Birks, Jacqueline, et al.
Publicado: (2017) -
Proteomic and genomic biomarkers for Non‐Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha‐1 antitrypsin
por: Najafi, Zahra, et al.
Publicado: (2020)